What is the recommended dosage of Bactrim (trimethoprim/sulfamethoxazole) for treating cellulitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bactrim Dosage for Cellulitis

For purulent cellulitis with suspected MRSA, prescribe Bactrim (trimethoprim-sulfamethoxazole) 1-2 double-strength tablets (160/800 mg) orally twice daily for 5-6 days. 1

Dosing by Cellulitis Type

Purulent Cellulitis (with drainage, pus, or abscess)

  • Adult dose: 1-2 double-strength (DS) tablets (160/800 mg) orally twice daily 1
  • Pediatric dose: Trimethoprim 4-6 mg/kg/dose, sulfamethoxazole 20-30 mg/kg/dose orally every 12 hours 1
  • Duration: 5-6 days 1

Nonpurulent Cellulitis (no drainage or pus)

Bactrim is NOT recommended as first-line therapy for nonpurulent cellulitis because its activity against β-hemolytic streptococci (the primary pathogen) is not well-defined. 1 Beta-lactams like cephalexin (500 mg orally four times daily) should be used instead. 1

Key Clinical Considerations

When to Use Bactrim

Bactrim is appropriate when:

  • Purulent drainage is present (indicates likely MRSA involvement) 1
  • Patient has failed beta-lactam therapy for nonpurulent cellulitis 1
  • Systemic toxicity is present in nonpurulent cellulitis (consider adding MRSA coverage) 1
  • Local MRSA prevalence is high and clinical suspicion warrants coverage 2

Important Contraindications

  • Pregnancy: Category C/D - not recommended in third trimester 1
  • Infants: Not recommended for children <2 months of age 1

Treatment Duration Evidence

Five days of antibiotic therapy is as effective as 10 days for uncomplicated cellulitis. 1, 3, 4 The American College of Physicians recommends 5-6 days for nonpurulent cellulitis in patients who can self-monitor with close follow-up. 1 Research demonstrates no additional benefit from courses longer than 5 days. 3, 4

Common Pitfalls to Avoid

Coverage Gap for Streptococci

The most critical pitfall is using Bactrim alone for typical (nonpurulent) cellulitis. 1 TMP-SMX has excellent activity against community-associated MRSA but unreliable activity against β-hemolytic streptococci, which cause most nonpurulent cellulitis. 1 A randomized trial showed that adding TMP-SMX to cephalexin provided no benefit over cephalexin alone for nonpurulent cellulitis. 5

When Bactrim Monotherapy Fails

If a patient with purulent cellulitis on Bactrim is not improving, consider:

  • Inadequate source control (abscess requiring drainage) 1
  • Streptococcal co-infection requiring beta-lactam addition 1
  • Complicated infection requiring IV therapy (vancomycin 15-20 mg/kg IV every 8-12 hours) 1

Severity Indicators Requiring Hospitalization

Do not use oral Bactrim if the patient has: 1

  • Systemic toxicity or sepsis
  • Rapidly progressive infection despite oral antibiotics
  • Multiple infection sites
  • Significant comorbidities (diabetes, immunosuppression, HIV/AIDS)
  • Extremes of age with severe disease
  • Inability to take oral medications

Alternative Regimens for Purulent Cellulitis

If Bactrim cannot be used:

  • Clindamycin: 300-450 mg orally three times daily (covers both MRSA and streptococci, but higher C. difficile risk) 1
  • Doxycycline: 100 mg orally twice daily (not for children <8 years or pregnancy) 1
  • Linezolid: 600 mg orally twice daily (more expensive) 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.